{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:25:23Z","timestamp":1763346323048,"version":"3.45.0"},"reference-count":75,"publisher":"Tech Science Press","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2025.066783","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:25:39Z","timestamp":1757924739000},"page":"3493-3522","source":"Crossref","is-referenced-by-count":0,"title":["Construction of a Prognostic Model of Prostate Cancer Based on Immune and Metabolic Genes and Experimental Validation of the Gene AK5"],"prefix":"10.32604","volume":"33","author":[{"given":"Wenjie","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 update on prostate cancer epidemiology and risk factors\u2014a systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur Urol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","article-title":"Recent global patterns in prostate cancer incidence and mortality rates","volume":"77","author":"Culp","year":"2020","journal-title":"Eur Urol"},{"key":"ref3","first-page":"1","article-title":"The contemporary management of prostate cancer","volume":"50","author":"Chakrabarti","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"ref4","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ijrobp.2024.12.011","article-title":"Evolution of image guidance and adaptive radiation therapy for localized prostate cancer","volume":"122","author":"Patel","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11864-023-01162-4","article-title":"Surgical management and considerations for patients with localized high-risk prostate cancer","volume":"25","author":"Fang","year":"2024","journal-title":"Curr Treat Options Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2021.05.016","article-title":"Overall survival of men with metachronous metastatic hormone-sensitive prostate cancer treated with enzalutamide and androgen deprivation therapy","volume":"80","author":"Sweeney","year":"2021","journal-title":"Eur Urol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1200\/JCO.23.01535","article-title":"Radiographic progression-free survival and clinical progression-free survival as potential surrogates for overall survival in men with metastatic hormone-sensitive prostate cancer","volume":"42","author":"Halabi","year":"2024","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1200\/JCO.23.00723","article-title":"Early treatment intensification in metastatic hormone-sensitive prostate cancer","volume":"41","author":"Wala","year":"2023","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1470-2045(21)00705-1","article-title":"Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis","volume":"23","author":"Kishan","year":"2022","journal-title":"Lancet Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.eururo.2021.12.039","article-title":"Pre-existing castration-resistant prostate cancer-like cells in primary prostate cancer promote resistance to hormonal therapy","volume":"81","author":"Cheng","year":"2022","journal-title":"Eur Urol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41585-021-00470-4","article-title":"Treatment and trials in non-metastatic castration-resistant prostate cancer","volume":"18","author":"Lokeshwar","year":"2021","journal-title":"Nat Rev Urol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"106709","DOI":"10.1016\/j.intimp.2020.106709","article-title":"Exploration of gene expression profiles and immune microenvironment between high and low tumor mutation burden groups in prostate cancer","volume":"86","author":"Luo","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12935-025-03738-6","article-title":"Fatty acid metabolism related gene MECR contributes to the progression of prostate cancer","volume":"25","author":"Liu","year":"2025","journal-title":"Cancer Cell Int"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1001297","DOI":"10.3389\/fimmu.2022.1001297","article-title":"Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41467-021-27322-4","article-title":"Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states","volume":"13","author":"Song","year":"2022","journal-title":"Nat Commun"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s43587-025-00842-0","article-title":"Single-cell and spatial RNA sequencing identify divergent microenvironments and progression signatures in early-versus late-onset prostate cancer","volume":"5","author":"Cheng","year":"2025","journal-title":"Nat Aging"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e2305724","DOI":"10.1002\/advs.202305724","article-title":"Integration analysis of single-cell multi-omics reveals prostate cancer heterogeneity","volume":"11","author":"Bian","year":"2024","journal-title":"Adv Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1122670","DOI":"10.3389\/fimmu.2023.1122670","article-title":"Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2025.0228","article-title":"Prostate cancer: a review","volume":"333","author":"Raychaudhuri","year":"2025","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e2434622","DOI":"10.1001\/jamanetworkopen.2024.34622","article-title":"Incidence, prevalence, and survival of prostate cancer in the UK","volume":"7","author":"Tan","year":"2024","journal-title":"JAMA Netw Open"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/brain\/awab153","article-title":"Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis","volume":"144","author":"Mu\u00f1iz-Castrillo","year":"2021","journal-title":"Brain"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jns.2016.04.037","article-title":"Down-regulation of adenylate kinase 5 in temporal lobe epilepsy patients and rat model","volume":"366","author":"Lai","year":"2016","journal-title":"J Neurol Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/carcin\/bgt316","article-title":"Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K\/Akt\/FoxO pathway","volume":"35","author":"Shukla","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.7150\/thno.82920","article-title":"The role of lipid metabolic reprogramming in tumor microenvironment","volume":"13","author":"Yang","year":"2023","journal-title":"Theranostics"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","volume":"5","author":"Tharp","year":"2024","journal-title":"Nat Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.immuni.2024.03.021","article-title":"25-Hydroxycholesterol regulates lysosome AMP kinase activation and metabolic reprogramming to educate immunosuppressive macrophages","volume":"57","author":"Xiao","year":"2024","journal-title":"Immunity"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3390\/ijms24020910","article-title":"Emerging hallmarks of metabolic reprogramming in prostate cancer","volume":"24","author":"Lasorsa","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"217441","DOI":"10.1016\/j.canlet.2025.217441","article-title":"Metabolic reprogramming, malignant transformation and metastasis: lessons from chronic lymphocytic leukaemia and prostate cancer","volume":"611","author":"Hindes","year":"2025","journal-title":"Cancer Lett"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.semcancer.2020.12.002","article-title":"Metabolic regulation of prostate cancer heterogeneity and plasticity","volume":"82","author":"Peitzsch","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/s41379-018-0083-x","article-title":"Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer","volume":"31","author":"Kaur","year":"2018","journal-title":"Mod Pathol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1364329","DOI":"10.3389\/fimmu.2024.1364329","volume":"15","author":"Fan","year":"2024","journal-title":"Front Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.euf.2017.05.013","article-title":"PD-L1 Expression and CD8(+) T-cell Infiltrate are associated with clinical progression in patients with node-positive prostate cancer","volume":"5","author":"Petitprez","year":"2019","journal-title":"Eur Urol Focus"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e7118","DOI":"10.1002\/cam4.7118","article-title":"Patterns of B-cell lymphocyte expression changes in pre- and post-malignant prostate tissue are associated with prostate cancer progression","volume":"13","author":"Sadasivan","year":"2024","journal-title":"Cancer Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1479-5876-12-30","article-title":"Tumor infiltrating B-cells are increased in prostate cancer tissue","volume":"12","author":"Woo","year":"2014","journal-title":"J Transl Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2393442","DOI":"10.1080\/2162402X.2024.2393442","article-title":"Secreted factors from M1 macrophages drive prostate cancer stem cell plasticity by upregulating NANOG, SOX2, and CD44 through NF\u03baB-signaling","volume":"13","author":"Kainulainen","year":"2024","journal-title":"Oncoimmunology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e006020","DOI":"10.1136\/jitc-2022-006020","article-title":"YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6","volume":"11","author":"Chen","year":"2023","journal-title":"J Immunother Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/onc.2013.191","article-title":"Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression","volume":"33","author":"Comito","year":"2014","journal-title":"Oncogene"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1038\/s41467-022-34871-9","article-title":"ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression","volume":"13","author":"Li","year":"2022","journal-title":"Nat Commun"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41391-022-00615-5","article-title":"Circulating myeloid-derived suppressor cells and survival in prostate cancer patients: systematic review and meta-analysis","volume":"26","author":"Bronte","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"T95","DOI":"10.1530\/ERC-21-0149","article-title":"The tumor microenvironment and immune responses in prostate cancer patients","volume":"28","author":"Kwon","year":"2021","journal-title":"Endocr Relat Cancer"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/1878-0261.13441","article-title":"Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer","volume":"17","author":"Gonthier","year":"2023","journal-title":"Mol Oncol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/path.4547","article-title":"A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy","volume":"236","author":"Pertega-Gomes","year":"2015","journal-title":"J Pathol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ijc.21411","article-title":"Zinc blocks gene expression of mitochondrial aconitase in human prostatic carcinoma cells","volume":"118","author":"Tsui","year":"2006","journal-title":"Int J Cancer"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.semcdb.2012.02.002","article-title":"Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis","volume":"23","author":"Daye","year":"2012","journal-title":"Semin Cell Dev Biol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1158\/0008-5472.CAN-21-0914","article-title":"Lactate rewires lipid metabolism and sustains a metabolic-epigenetic axis in prostate cancer","volume":"82","author":"Ippolito","year":"2022","journal-title":"Cancer Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/nu14040851","article-title":"Lipid metabolism and epigenetics crosstalk in prostate cancer","volume":"14","author":"Pardo","year":"2022","journal-title":"Nutrients"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/aja202363","article-title":"Lipid metabolism, amino acid metabolism, and prostate cancer: a crucial metabolic journey","volume":"26","author":"Chen","year":"2024","journal-title":"Asian J Androl"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"eaau5758","DOI":"10.1126\/scitranslmed.aau5758","article-title":"Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer","volume":"11","author":"Watt","year":"2019","journal-title":"Sci Transl Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/med.21766","article-title":"Revisiting prostate cancer metabolism: from metabolites to disease and therapy","volume":"41","author":"Cardoso","year":"2021","journal-title":"Med Res Rev"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1002\/cncr.30071","article-title":"Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: results from the prostate cancer prevention trial","volume":"122","author":"Price","year":"2016","journal-title":"Cancer"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41419-025-07449-8","article-title":"Lon protease 1-mediated metabolic reprogramming promotes the progression of prostate cancer","volume":"16","author":"Yao","year":"2025","journal-title":"Cell Death Dis"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ijc.10127","article-title":"Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer","volume":"98","author":"Swinnen","year":"2002","journal-title":"Int J Cancer"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/onc.2017.385","article-title":"Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer","volume":"37","author":"Han","year":"2018","journal-title":"Oncogene"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41568-020-0273-y","article-title":"Metabolism of immune cells in cancer","volume":"20","author":"Leone","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41591-019-0404-8","article-title":"The landscape of cancer cell line metabolism","volume":"25","author":"Li","year":"2019","journal-title":"Nat Med"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"26217","DOI":"10.1038\/s41598-024-78085-z","article-title":"The relationship between immune cells and prostate cancer, and the mediating role of metabolites: a Mendelian randomization study","volume":"14","author":"Wu","year":"2024","journal-title":"Sci Rep"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12885-022-09331-8","article-title":"Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients","volume":"22","author":"Zhao","year":"2022","journal-title":"BMC Cancer"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1049\/syb2.12097","article-title":"A tumour-associated macrophage-based signature for deciphering prognosis and immunotherapy response in prostate cancer","volume":"18","author":"Wang","year":"2024","journal-title":"IET Syst Biol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1564784","DOI":"10.3389\/fimmu.2025.1564784","article-title":"Identification of the gene signatures related to NK\/T cell communication to evaluate the tumor microenvironment and prognostic outcomes of patients with prostate adenocarcinoma","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12672-025-01862-3","volume":"16","author":"Zhou","year":"2025","journal-title":"Discov Oncol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1186\/s12885-024-12593-z","article-title":"Analysis of the immune-inflammatory indices for patients with metastatic hormone-sensitive and castration-resistant prostate cancer","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Cancer"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1426474","DOI":"10.3389\/fimmu.2024.1426474","article-title":"Multi-omics analysis and experimental validation of the value of monocyte-associated features in prostate cancer prognosis and immunotherapy","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s12672-025-02484-5","article-title":"Development of a machine learning-based predictive risk model combining fatty acid metabolism and ferroptosis for immunotherapy response and prognosis in prostate cancer","volume":"16","author":"Wang","year":"2025","journal-title":"Discov Oncol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"108323","DOI":"10.1016\/j.compbiolchem.2024.108323","article-title":"Identification and dissection of prostate cancer grounded on fatty acid metabolism-correlative features for predicting prognosis and assisting immunotherapy","volume":"115","author":"Zheng","year":"2025","journal-title":"Comput Biol Chem"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrmicro3344","article-title":"The gut microbiota, bacterial metabolites and colorectal cancer","volume":"12","author":"Louis","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11033-025-10311-x","article-title":"Single-cell sequencing reveals that AK5 inhibits apoptosis in AD oligodendrocytes by regulating the AMPK signaling pathway","volume":"52","author":"Yang","year":"2025","journal-title":"Mol Biol Rep"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/1440-1681.13680","article-title":"Low adenylate kinase 5 expression is predictive of poor prognosis and promotes tumour growth by regulating the cell-cycle pathway","volume":"49","author":"Zhang","year":"2022","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.techscience.cn\/files\/or\/2025\/TSP_OR-33-11\/OncolRes-33-11-66783\/OncolRes-33-66783.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:21:22Z","timestamp":1763346082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n11\/64069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":75,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2025.066783","relation":{},"ISSN":["1555-3906"],"issn-type":[{"type":"electronic","value":"1555-3906"}],"subject":[],"published":{"date-parts":[[2025]]}}}